ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,1,Headache,Headaches NEC,Headaches,Nerv,N
5,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
7,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
7,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
8,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10,2,Headache,Headaches NEC,Headaches,Nerv,N
10,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
10,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
12,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
13,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
